Magnesium Sulfate Injection (Hospira) – superpotent drug (2012)
Class III: A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences
Class III recall indicates unlikely adverse health consequences.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Magnesium Sulfate in Water for Injection, 40 mg/mL (0.325 mEq Mg++/mL), 2 g total, 50 mL Flexible Container, Rx only, Hospira, Inc., Lake Forest, IL 60045; NDC 0409-6729-24.
Brand
Hospira, Inc.
Lot Codes / Batch Numbers
Lot #: 04510KL*, Exp 01OCT2012, *lot number may have 01 or 02 following it
Products Sold
Lot #: 04510KL*, Exp 01OCT2012; *lot number may have 01 or 02 following it
Hospira, Inc. is recalling Magnesium Sulfate in Water for Injection, 40 mg/mL (0.325 mEq Mg++/mL), 2 g total, 50 mL Flexible Co due to Superpotent (Single Ingredient) Drug: Above specification assay results for percentage of magnesium sulfate.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Superpotent (Single Ingredient) Drug: Above specification assay results for percentage of magnesium sulfate.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026